News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
264,928 Results
Type
Article (14120)
Company Profile (282)
Press Release (250526)
Section
Business (79464)
Career Advice (152)
Deals (13221)
Drug Delivery (35)
Drug Development (50408)
Employer Resources (31)
FDA (5705)
Job Trends (5125)
News (144308)
Policy (10025)
Tag
Academia (906)
Alliances (21613)
Alzheimer's disease (800)
Antibody-drug conjugate (ADC) (78)
Approvals (5710)
Artificial intelligence (98)
Bankruptcy (102)
Best Places to Work (4560)
Biotechnology (232)
Breast cancer (132)
Cancer (1145)
Cardiovascular disease (92)
Career advice (132)
CAR-T (98)
Cell therapy (285)
Clinical research (40609)
Collaboration (453)
Compensation (186)
COVID-19 (1028)
C-suite (122)
Cystic fibrosis (75)
Data (1181)
Diabetes (108)
Diagnostics (1282)
Earnings (29309)
Events (47786)
Executive appointments (368)
FDA (6229)
Funding (422)
Gene editing (79)
Gene therapy (207)
GLP-1 (340)
Government (1072)
Healthcare (6578)
Infectious disease (1080)
Inflammatory bowel disease (106)
IPO (7249)
Job creations (859)
Job search strategy (127)
Layoffs (197)
Legal (1384)
Lung cancer (164)
Manufacturing (105)
Medical device (2580)
Medtech (2581)
Mergers & acquisitions (6210)
Metabolic disorders (324)
Neuroscience (1125)
NextGen: Class of 2025 (2012)
Non-profit (852)
Northern California (1375)
Obesity (168)
Opinion (98)
Parkinson's disease (90)
Patents (92)
People (25387)
Phase I (14334)
Phase II (18895)
Phase III (11936)
Pipeline (548)
Postmarket research (852)
Preclinical (6005)
Radiopharmaceuticals (210)
Rare diseases (253)
Real estate (1414)
Regulatory (8461)
Research institute (935)
Series A (82)
Southern California (1231)
Startups (1969)
United States (10893)
Vaccines (192)
Weight loss (96)
Date
Today (63)
Last 7 days (466)
Last 30 days (1666)
Last 365 days (20361)
2025 (3106)
2024 (20552)
2023 (22414)
2022 (26822)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Asia (17121)
Australia (2896)
California (3147)
Canada (980)
China (281)
Colorado (119)
Connecticut (132)
Delaware (75)
Europe (36819)
Florida (365)
Georgia (93)
Illinois (195)
Indiana (76)
Maryland (409)
Massachusetts (2494)
Minnesota (123)
New Jersey (784)
New York (870)
North Carolina (485)
Northern California (1375)
Ohio (99)
Pennsylvania (593)
South America (207)
Southern California (1231)
Texas (350)
Washington State (296)
264,928 Results for "ennaid therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Ennaid Therapeutics Announces Development of ENU200, A New Antiviral Therapeutic for the Treatment of COVID-19
Ennaid Therapeutics, LLC, a specialty pharmaceutical company that uses its artificial intelligence (AI)-based drug discovery platforms to develop antiviral drugs, today announced that it is advanci
April 2, 2020
·
3 min read
Layoffs
Repare Therapeutics to Cut Staff Again, This Time by 75%
The latest Repare Therapeutics layoffs will include its chief medical officer and could leave the biotech with fewer than 35 employees as it works to advance two Phase I clinical programs.
February 25, 2025
·
2 min read
·
Angela Gabriel
Press Releases
Allogene Therapeutics Announces Participation in March Investor Conference
February 26, 2025
·
2 min read
Press Releases
C4 Therapeutics to Participate in Upcoming March Investor Conferences
February 24, 2025
·
1 min read
Press Releases
Tango Therapeutics to Present at Three Upcoming Investment Bank Conferences
February 20, 2025
·
1 min read
Press Releases
MiNK Therapeutics Regains Full Compliance with Nasdaq Listing Requirements
February 20, 2025
·
1 min read
Press Releases
Allogene Therapeutics Announces Participation in February Investor Conferences
February 4, 2025
·
2 min read
Press Releases
Denali Therapeutics Announces Upcoming Presentations on Hunter Syndrome (MPS II) and TransportVehicle™ Enabled Investigational Therapeutic Tividenofusp Alfa at the 2025 WORLDSymposium™
January 30, 2025
·
4 min read
Press Releases
MaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell Therapeutics Programs
February 12, 2025
·
6 min read
1 of 26,493
Next
